tiprankstipranks
Trending News
More News >
HitIQ Limited (AU:HIQ)
ASX:HIQ
Australian Market

HitIQ Limited (HIQ) AI Stock Analysis

Compare
2 Followers

Top Page

AU

HitIQ Limited

(Sydney:HIQ)

40Underperform
HitIQ Limited exhibits robust revenue growth but is plagued by significant profitability and liquidity challenges, reflected in the financial performance score. Technical indicators suggest weak market momentum, contributing to a low technical analysis score. The negative P/E ratio and absence of dividend yield further exacerbate valuation concerns, resulting in an overall score towards the lower end of the spectrum. The company's financial risks and lack of favorable market sentiment present a challenging outlook.

HitIQ Limited (HIQ) vs. S&P 500 (SPY)

HitIQ Limited Business Overview & Revenue Model

Company DescriptionHitIQ Limited (HIQ) is a technology company operating in the sports and health sectors. The company specializes in developing innovative solutions that focus on the detection, management, and prevention of head injuries. HitIQ's core products include wearable sensor technology and data analytics platforms designed to monitor and assess impact events, primarily in contact sports.
How the Company Makes MoneyHitIQ Limited makes money through the sale and licensing of its proprietary wearable sensor technology and related software platforms to sports organizations, teams, and leagues. The company generates revenue by providing its products as a subscription service, offering analytics and insights through its data platforms. Key revenue streams include direct sales, subscription fees, and potential collaborations with sports health institutions. Significant partnerships with sports organizations and health research entities further contribute to its earnings by expanding its market reach and enhancing the credibility of its technology.

HitIQ Limited Financial Statement Overview

Summary
HitIQ Limited shows strong revenue growth but faces significant profitability and liquidity challenges. The persistent negative net income and high leverage represent financial risks. The company's reliance on external financing to support operations indicates a precarious financial situation. Strategic improvements in operational efficiency and capital management are necessary to enhance financial stability.
Income Statement
40
Negative
The company has demonstrated significant revenue growth from $402,259 in 2020 to $4,748,879 in 2024, showcasing robust topline expansion. However, the company consistently records negative EBIT and net income, indicating ongoing operational challenges and profitability issues. Gross profit margin is low, and net profit margin remains negative, reflecting struggles in cost management and achieving profitability.
Balance Sheet
30
Negative
The balance sheet shows high leverage with a total debt exceeding stockholders' equity, resulting in a negative equity position by 2024. The debt-to-equity ratio is not meaningful due to negative equity. The equity ratio is also negative, highlighting potential financial instability and risk in the capital structure.
Cash Flow
35
Negative
Operating cash flows are consistently negative, indicating cash burn from operations. Free cash flow is also negative, suggesting that the company is reliant on external financing, evident from financing cash flows in 2024. The operating cash flow to net income ratio is not favorable, underscoring cash management issues.
Breakdown
TTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income StatementTotal Revenue
1.70M4.75M774.26K619.02K406.68K40.26K
Gross Profit
-600.45K334.63K242.73K250.05K-3.28M-2.75M
EBIT
-5.62M-2.56M-7.34M-6.91M-5.01M-3.76M
EBITDA
-3.71M-2.54M-4.31M-6.54M-4.79M-2.32M
Net Income Common Stockholders
-4.75M-3.20M-5.04M-6.95M-5.06M-2.62M
Balance SheetCash, Cash Equivalents and Short-Term Investments
854.11K584.02K1.98M2.94M8.96M428.03K
Total Assets
1.82M3.73M3.13M4.55M9.49M2.08M
Total Debt
22.65K3.20M1.69M2.16M709.34K1.16M
Net Debt
-831.46K2.61M-284.14K-779.18K-8.25M729.35K
Total Liabilities
1.62M5.20M3.18M3.38M1.56M1.70M
Stockholders Equity
205.82K-1.47M-46.86K1.17M7.92M386.86K
Cash FlowFree Cash Flow
-5.68M-4.12M-4.57M-6.57M-2.18M-2.37M
Operating Cash Flow
-5.65M-4.10M-4.51M-6.51M-2.13M-2.31M
Investing Cash Flow
-30.36K-20.78K-54.73K-918.06K-54.84K-63.97K
Financing Cash Flow
5.49M2.73M3.61M1.41M10.71M2.53M

HitIQ Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.04
Negative
100DMA
0.04
Negative
200DMA
0.03
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
44.63
Neutral
STOCH
35.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:HIQ, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.04, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 44.63 is Neutral, neither overbought nor oversold. The STOCH value of 35.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:HIQ.

HitIQ Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AUCAT
68
Neutral
$1.03B-19.56%17.79%11.08%
AURHT
59
Neutral
AU$18.38M140.00-3.11%89.13%69.57%
51
Neutral
$5.32B3.32-40.25%2.90%17.93%2.14%
AUSEN
44
Neutral
AU$31.46M-31.58%22.29%64.62%
AUHIQ
40
Underperform
AU$9.23M
18.53%33.17%
AUNXS
39
Underperform
AU$29.22M-130.18%3.37%47.32%
AUBRN
34
Underperform
$541.09M-133.28%72.47%20.08%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:HIQ
HitIQ Limited
0.02
>-0.01
-33.33%
AU:SEN
Senetas Corporation Limited
0.02
0.01
100.00%
AU:NXS
Next Science Ltd
0.10
-0.24
-70.59%
AU:CAT
Catapult Group International Ltd.
3.90
2.41
161.74%
AU:BRN
BrainChip Holdings
0.27
-0.03
-11.48%
AU:RHT
Resonance Health Ltd
0.04
-0.04
-50.00%

HitIQ Limited Corporate Events

HITIQ Issues Shares to Enhance Investor Relations
Apr 14, 2025

HITIQ Limited announced the issuance of 1,000,000 fully paid ordinary shares to fulfill investor relations services. This move, executed without disclosure under specific provisions of the Corporations Act, signifies HITIQ’s compliance with relevant regulatory requirements and reflects its strategic efforts to strengthen investor relations. The announcement underscores HITIQ’s commitment to transparency and adherence to corporate governance standards, potentially bolstering its market position and stakeholder confidence.

HITIQ Secures Additional $220,000 in R&D Tax Incentive Loan
Apr 14, 2025

HITIQ Limited has drawn an additional $220,000 from its secured loan facility with Rockford RDF Pty Ltd, bringing the total to $1,020,000. This drawdown provides early access to their forecasted 2025 R&D Tax Incentive, with repayment expected upon receipt of the RDTI refund by the end of 2025. This financial maneuver is consistent with previous company announcements and reflects strategic financial planning to support ongoing operations.

HitIQ Limited Announces Quotation of New Securities on ASX
Apr 14, 2025

HitIQ Limited has announced the quotation of 1,000,000 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective April 14, 2025. This move is part of a previously announced transaction and is expected to strengthen the company’s market presence and provide additional capital for its operations, potentially impacting stakeholders positively by enhancing the company’s financial flexibility.

HitIQ Limited Announces Proposed Securities Issue
Apr 11, 2025

HitIQ Limited has announced a proposed issue of 1,000,000 ordinary fully paid securities, with the issuance scheduled for April 14, 2025. This move is part of a placement or other type of issue, and the company has applied for the quotation of these securities on the ASX, which may impact its market presence and investor relations.

HITIQ Limited Issues Shares for Investor Relations Services
Apr 11, 2025

HITIQ Limited has issued 1,000,000 new ordinary shares to settle a $30,000 debt with an external Investor Relations service provider, using its ASX Listing Rule 7.1 placement capacity. This move reflects the company’s strategy to prioritize capital towards business operations, potentially impacting its financial management and stakeholder relations.

HitIQ Limited Announces Cessation of 1.5 Million Securities
Mar 27, 2025

HitIQ Limited announced the cessation of 1,500,000 securities due to the expiry of options without exercise or conversion, effective March 25, 2025. This development may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and market positioning.

HitIQ Targets Consumer Market with VAFA Partnership
Mar 24, 2025

HitIQ Limited has announced a strategic shift towards the consumer market, specifically targeting amateur and community-level athletes with its HITIQ PROTEQT system. This move is supported by a three-year partnership with the Victorian Amateur Football Association (VAFA), positioning HitIQ as the official concussion technology partner. The partnership aims to leverage HitIQ’s elite-level technology to address the growing demand for concussion safety solutions among amateur athletes. By integrating their proven technology into an affordable product, HitIQ aims to drive adoption and achieve a cash flow positive future, ultimately enhancing player safety and expanding their market presence.

HitIQ Limited Reports Increased Losses and Revenue Decline for H2 2024
Feb 28, 2025

HitIQ Limited reported a reduction in revenues and an increase in losses for the half-year ended December 31, 2024, compared to the previous year. The company did not declare any dividends for this period, and its net tangible assets per share decreased significantly, indicating financial challenges that may impact its market position and stakeholder confidence.

HitIQ Limited Proposes New Securities Issue to Bolster Market Position
Feb 24, 2025

HitIQ Limited has announced a proposed issue of securities, which includes issuing 14,700,000 performance rights and 800,000 fully paid ordinary employee shares. This strategic move is aimed at strengthening the company’s market position and supporting its growth objectives, potentially enhancing its competitive edge in the wearable sports technology sector.

HITIQ Secures New $800,000 R&D Loan Facility for 2025
Feb 21, 2025

HITIQ Limited has announced the establishment of a new loan facility agreement, providing early access to R&D expenditure for the 2025 financial year. The facility, amounting to $800,000, is structured with terms consistent with previous agreements, including a 15% interest rate and a maturity date 365 days from the agreement. This development is anticipated to bolster HITIQ’s operational capacity, potentially enhancing its industry standing by leveraging the funding for further innovation and market competitiveness.

HITIQ Secures Early Access to R&D Tax Incentive Funds
Feb 21, 2025

HITIQ Limited has secured a loan facility with Rockford RDF Pty Ltd to gain early access to $800,000 from its forecast 2025 R&D Tax Incentive. This immediate fund access strengthens HITIQ’s financial position, allowing it to focus on its strategic priorities. The loan, based on incurred R&D expenses and expected tax incentives, will be repaid upon receiving the 2025 R&D Tax Incentive refund by December 2025.

HitIQ Limited Announces Quotation of New Securities on ASX
Feb 3, 2025

HitIQ Limited announced the quotation of 5,248,043 fully paid ordinary securities on the ASX, effective from February 3, 2025. This move is part of previously announced transactions, and it signifies a strategic step in enhancing the company’s market presence and liquidity, potentially impacting investor interest and expanding its capital base.

HitIQ Limited Appoints New Director Jennifer Tucker
Jan 31, 2025

HitIQ Limited has announced the appointment of Jennifer Tucker as a new director, effective February 1, 2025. This appointment does not involve any initial interests in securities or contracts, indicating a fresh start for Tucker in this role, potentially impacting the company’s strategic direction without prior encumbrances.

HITIQ Strengthens Board with New Appointment
Jan 31, 2025

HITIQ Limited has appointed Jennifer Tucker to its Board as a Non-Executive Director, effective February 1, 2025. With extensive experience in the retail and consumer goods sector, Ms. Tucker is expected to enhance the company’s governance and strategic oversight, supporting HITIQ’s growth strategy in expanding its consumer offerings. This appointment reflects HITIQ’s dedication to strengthening its leadership team to advance its mission in concussion management technologies globally.

HitIQ Limited Announces New Securities Issue to Boost Capital
Jan 31, 2025

HitIQ Limited has announced a new securities issue with a maximum of 5,248,043 fully paid ordinary shares to be issued. This move is part of HitIQ’s strategy to strengthen its financial position and enhance its market presence. The announcement could have significant implications for the company’s operations and its stakeholders, as it suggests a potential increase in capital that may be used for further growth or investment opportunities.

HITIQ Announces Note Conversion and Strategic Moves to Bolster Growth
Jan 31, 2025

HITIQ Limited announced that its largest shareholder, Harmil Angel Investments, intends to convert $1.6 million of convertible notes into ordinary shares, with a premium conversion price set above the initial discount. This conversion will require regulatory compliance and the issuance of an Independent Expert’s Report. Additionally, the company has revised its Corporate Advisory Mandate with Henslow Pty Ltd to attract US-based investors, and intends to settle debts with external service providers by issuing new shares, maintaining focus on operational capital prioritization.

HITIQ Expands Premier League Partnership and Strengthens Leadership
Jan 30, 2025

HITIQ Limited has extended its partnership with the Premier League by 18 months, increasing the annual contract value by 60%. This extension underscores the effectiveness and growing adoption of HITIQ’s concussion management technology, enhancing the company’s footprint in elite sports. Additionally, HITIQ appointed Chris Davis as Chief Marketing Officer to bolster its global marketing strategy and secured an additional $3 million through a convertible note facility to support production, sales, and global commercialization efforts. These developments are set to strengthen HITIQ’s market position and support its growth ambitions in the concussion management space.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.